Financial Situation of Listed Companies in Pharmaceutical Industry

DOI

10.2991/wrarm-17.2017.20How to use a DOI?

Keywords

Pharmaceutical industry; Fuzzy comprehensive evaluation method; Risk warning

Abstract

This paper studies the financial risks of listed companies in China's pharmaceutical industry by means of qualitative research and quantitative research. Based on the financial data of Guizhou bailing pharmaceutical co, ltd. in 2015 and 2016. The empirical analysis shows that: Based on the fuzzy comprehensive evaluation method, the financial situation analysis of the listed companies in the pharmaceutical industry is feasible in the first year and the year of T. The financial status of listed companies in the pharmaceutical industry can be used to predict the financial risks of the pharmaceutical industry listed company T 1 and 2 years.

Copyright

© 2017, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Haokun Yan
AU  - Ting Xu
PY  - 2017/11
DA  - 2017/11
TI  - Financial Situation of Listed Companies in Pharmaceutical Industry
BT  - Proceedings of the Fifth Symposium of Risk Analysis and Risk Management in Western China (WRARM 2017)
PB  - Atlantis Press
SP  - 110
EP  - 114
SN  - 1951-6851
UR  - https://doi.org/10.2991/wrarm-17.2017.20
DO  - 10.2991/wrarm-17.2017.20
ID  - Yan2017/11
ER  -